Oliver Lagore Vanvalin Investment Group’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $811K | Buy |
+11,039
| New | +$811K | 0.32% | 70 |
|
|
2024
Q4 | $1.08M | Buy |
16,420
+3,245
| +25% | +$213K | 0.28% | 70 |
|
|
2024
Q3 | $1.03M | Buy |
13,175
+1,627
| +14% | +$127K | 0.27% | 71 |
|
|
2024
Q2 | $901K | Sell |
11,548
-1,629
| -12% | -$127K | 0.26% | 68 |
|
|
2024
Q1 | $893K | Buy |
13,177
+13,163
| +94,021% | +$892K | 0.26% | 66 |
|
|
2023
Q4 | $943 | Sell |
14
-82
| -85% | -$5.52K | ﹤0.01% | 654 |
|
|
2023
Q3 | $6.51K | Sell |
96
-84
| -47% | -$5.7K | ﹤0.01% | 503 |
|
|
2023
Q2 | $12.9K | Buy |
180
+49
| +37% | +$3.51K | ﹤0.01% | 424 |
|
|
2023
Q1 | $9.1K | Buy |
131
+3
| +2% | +$208 | ﹤0.01% | 393 |
|
|
2022
Q4 | $8.68K | Buy |
128
+99
| +341% | +$6.71K | ﹤0.01% | 378 |
|
|
2022
Q3 | $2K | Hold |
29
| – | – | ﹤0.01% | 515 |
|
|
2022
Q2 | $2K | Buy |
29
+15
| +107% | +$1.03K | ﹤0.01% | 485 |
|
|
2022
Q1 | $1K | Buy |
+14
| New | +$1K | ﹤0.01% | 521 |
|